data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Zealand Pharma
(NASDAQ:ZEAL)
$13.09
0.08[0.61%]
At close: Jul 1
$11.78
-1.3100[-10.01%]
After Hours: 9:14AM EDT
Day High/Low12.82 - 13.1
52 Week High/Low9.93 - 34.3
Open / Close12.82 / 12.89
Float / Outstanding- / 43.2M
Vol / Avg.1.8K / 3.9K
Mkt Cap565.7M
P/E-
50d Avg. Price12.45
Div / Yield-
Payout Ratio-
EPS-5.16
Total Float-

Zealand Pharma (NASDAQ:ZEAL), Quotes and News Summary

Zealand Pharma (NASDAQ: ZEAL)

Day High/Low12.82 - 13.1
52 Week High/Low9.93 - 34.3
Open / Close12.82 / 12.89
Float / Outstanding- / 43.2M
Vol / Avg.1.8K / 3.9K
Mkt Cap565.7M
P/E-
50d Avg. Price12.45
Div / Yield-
Payout Ratio-
EPS-5.16
Total Float-
Benzinga - Jun 21, 2022, 9:03AM
Benzinga - Jun 1, 2022, 11:30AM
Benzinga - May 19, 2022, 10:34AM
Benzinga - May 19, 2022, 9:52AM
Benzinga - May 19, 2022, 9:36AM
Benzinga - May 19, 2022, 7:37AM
Benzinga - May 17, 2022, 11:04AM
Benzinga - May 17, 2022, 6:09AM
Benzinga - May 13, 2022, 5:03AM
Benzinga - May 12, 2022, 9:23AM
Benzinga - May 10, 2022, 10:15AM
Benzinga - Mar 30, 2022, 9:17AM
Benzinga - Mar 10, 2022, 9:03AM
Benzinga - Jan 20, 2022, 7:31AM
Benzinga - Dec 10, 2021, 8:34AM
Benzinga - Nov 22, 2021, 8:59AM
load more
Sector: Health Care.Industry: Biotechnology
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.940-0.780 0.1600
REV12.250M7.661M-4.589M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Zealand Pharma Questions & Answers

Q
How do I buy Zealand Pharma (ZEAL) stock?
A

You can purchase shares of Zealand Pharma (NASDAQ: ZEAL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Zealand Pharma's (ZEAL) competitors?
Q
What is the target price for Zealand Pharma (ZEAL) stock?
A

The latest price target for Zealand Pharma (NASDAQ: ZEAL) was reported by Needham on Friday, May 13, 2022. The analyst firm set a price target for 32.00 expecting ZEAL to rise to within 12 months (a possible 144.46% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Zealand Pharma (ZEAL)?
A

The stock price for Zealand Pharma (NASDAQ: ZEAL) is $13.09 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Zealand Pharma (ZEAL) pay a dividend?
A

There are no upcoming dividends for Zealand Pharma.

Q
When is Zealand Pharma (NASDAQ:ZEAL) reporting earnings?
A

Zealand Pharma’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Zealand Pharma (ZEAL) going to split?
A

There is no upcoming split for Zealand Pharma.

Q
What sector and industry does Zealand Pharma (ZEAL) operate in?
A

Zealand Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.